Kanagawa, Japan

Mitsuhiro Moriwaki

This inventor holds 1 USPTO granted patent. Top assignee: Toray Industries, Inc.. Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mitsuhiro Moriwaki. Retrieved from https://idiyas.com/inventor/mitsuhiro-moriwaki

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 28(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mitsuhiro Moriwaki: Innovator in Pharmaceutical Research

Introduction

Mitsuhiro Moriwaki is a notable inventor based in Kanagawa, Japan. He has made significant contributions to the field of pharmaceutical research, particularly in the development of novel compounds.

Latest Patents

Moriwaki holds 1 patent related to α1b-adrenergic receptor antagonists. This innovation showcases his expertise in creating therapeutic agents that can potentially improve patient outcomes.

Career Highlights

Moriwaki is currently employed at Toray Industries, Inc., a leading company in advanced materials and pharmaceuticals. His work at Toray has allowed him to focus on innovative solutions that address critical health challenges.

Collaborations

Throughout his career, Moriwaki has collaborated with esteemed colleagues such as Ryoji Hayashi and Eiji Ohmori. These partnerships have fostered a collaborative environment that enhances research and development efforts.

Conclusion

Mitsuhiro Moriwaki is a distinguished inventor whose work in pharmaceutical research continues to impact the industry positively. His contributions, particularly in the area of α1b-adrenergic receptor antagonists, highlight his commitment to innovation and improving healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…